Effects of Local Bacillus Calmette-Guerin Therapy in Patients with Bladder Carcinoma on Immunocompetent Cells of the Bladder Wall
- 1 July 1990
- journal article
- Published by Wolters Kluwer Health in Journal of Urology
- Vol. 144 (1), 53-58
- https://doi.org/10.1016/s0022-5347(17)39365-5
Abstract
The antitumoral effects of intravesical bacillus Calmette-Guerin against recurrent superficial urothelial bladder cancer seem to be linked to immunological effector mechanisms. To characterize further the local cellular response in the bladder wall of patients receiving intravesical bacillus Calmette-Guerin bladder biopsies were examined before and immediately after a 6-week course of bacillus Calmette-Guerin and for up to 1 year at 3-month intervals thereafter. The results showed a marked infiltration after bacillus Calmette-Guerin therapy predominantly of the suburothelial tissue with mononuclear cells, which expressed activation markers and accumulated to follicle-like granulomatous structures. With regard to T lymphocyte subsets the ratio of T helper-to-T suppressor cells in the bladder wall increased from 0.5 to nearly 2. This phenomenon persisted even in biopsies 1 year after initial treatment. In some probes activated mononuclear cells invaded the urothelium, emanating from suburothelial granulomas. It is tempting to assume that these changes within the local immunocompetent cells are related to the therapeutic effect of bacillus Calmette-Guerin against bladder cancer.Keywords
This publication has 34 references indexed in Scilit:
- Changes of the mucosal architecture and of urine cytology during BCG treatmentWorld Journal of Urology, 1988
- An Overview of Intravesical Therapy for Superficial Bladder TumorsJournal of Urology, 1987
- Local Immune Responses after Intravesical BCG Treatment for Carcinoma in situBritish Journal of Urology, 1987
- Prognostic Value of Purified Protein Derivative Skin Test and Granuloma Formation in Patients Treated with Intravesical Bacillus Calmette-GuerinJournal of Urology, 1986
- The Use of Bacillus Calmette-Guerin in the Therapy of Bladder Carcinoma in SituJournal of Urology, 1985
- Cytomorphological and histological studies on the urothelium during and after chemoimmune prophylaxisUrological Research, 1984
- Effect of intravesical bacillus calmette-guerin (BCG) on carcinomain situ of the bladderCancer, 1983
- Experience with Bacillus Calmette-Guerin in Patients with Superficial Bladder CarcinomaJournal of Urology, 1982
- BCG immunotherapy of bladder cancer: Inhibition of tumor recurrence and associated immune responsesCancer, 1981
- Intracavitary Bacillus Calmette-guerin in the Treatment of Superficial Bladder TumorsJournal of Urology, 1976